Short Decsription
Creative Biolabs offers CHO-K1-Tg(Human GPBA Receptor V88L) Stable Cell Line Line which GPBA Mutant V88L receptor stably expressed in CHO-K1 cells.
Description
CHO-K1-Tg(Human GPBA Receptor V88L) Stable Cell Line was engineered to express the receptor human GPBA receptor mutant V88L (NM_170699). The GPBA receptor responds to bile acids and is implicated in various physiological processes, including metabolic regulation, energy homeostasis, and immune responses. The V88L mutation involves the substitution of valine (V) at position 88 with leucine (L). This cell line can be used to study receptor pharmacology, signaling pathways, and potential therapeutic interventions.
Features
Minimally modified GPCRs directly selected in functional assays;
Strict quality control;
Parental and orthologous cell lines are available.
Applications
Receptor pharmacology, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPBA mutant V88L
Receptor Family
Bile Acid
Species
Human
Parental Cell Line
CHO-K1
Transfection
Expression vector containing full-length human GPBAR1 cDNA with V88L mutation with FLAG tag sequence at N-terminus
Gene
NM_170699
Background
The GPBA (TGR5) receptor plays crucial roles in various physiological processes, including metabolic regulation and immune responses. The V88L mutation, involving the substitution of valine with leucine at position 88, can impact the receptor's structure, ligand binding, and signaling functions. Research into this mutation can provide insights into its physiological and pathological consequences, potentially guiding therapeutic strategies for related disorders.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.